跳至主要内容
临床试验/NCT05176535
NCT05176535已完成不适用

Study to Determine Vaginal Colonization and Effect of an Oral Probiotic That Contains L.Rhamnosus, L. Plantarum and L. Crispatus in Women (PROSALVAG)

Fertypharm2 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2021年10月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
32
试验地点
2
主要终点
Rectal and vaginal colonization

研究概览

简要总结

The aim of this study is to determine the efficacy of an oral nutraceutical with probiotics in restore vaginal health.

详细描述

After being informed about the study, all patients meeting the inclusion/exclusion criteria and giving written informed consent will receive a nutraceutical containing L. rhamnosus, L. plantarum and L. crispatus once daily.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
35 Years 至 43 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Aged: 35-43 years old
  • Vaginal pH > 4,5 and low Lactobacillus count or Nugent score of 4-6
  • With interest in getting pregnant and ideally in IVF waiting list
  • History of recurrent genitourinary infections

排除标准

  • Any pathology that interferes with the study
  • Current intake of food supplements or probiotics
  • Current intake of contraceptives
  • Use of oral or vaginal probiotics in the last 6 months
  • Hypersensitivity to any of the components of the studied product
  • Current vaginal infection
  • Pregnant women
  • Breastfeeding
  • Use of intrauterine device
  • Use of spermicide
  • Use of cervical caps as hormonal therapy

结局指标

主要结局

Rectal and vaginal colonization

时间窗: 10 weeks

Rectal and vaginal colonization will be evaluated by measuring massive sequencing of 16SrRNA gen

次要结局

  • Antioxidant effect(10 weeks)
  • Autoinmune capacity(10 weeks)

研究者

发起方
Fertypharm
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验